MA
PCVX icon

MCF Advisors’s Vaxcyte PCVX Stock Holding History

MCF Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.64K Hold
97
– – ﹤0.01% 1136
2026
Q1 		$5.64K Hold
97
– – ﹤0.01% 1077
2025
Q4 		$4.48K Hold
97
– – ﹤0.01% 964
2025
Q3 		$3.49K Hold
97
– – ﹤0.01% 842
2025
Q2 		$3.15K Hold
97
– – ﹤0.01% 783
2025
Q1 		$3.66K Sell
97
-3
-3% -$240 ﹤0.01% 771
2024
Q4 		$8.19K Hold
100
– – ﹤0.01% 695
2024
Q3 		$11.4K Buy
+100
New +$9.01K ﹤0.01% 630

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

MCF Advisors's PCVX Position: Q2 2026 in Review

MCF Advisors held its Vaxcyte (PCVX) position steady in Q2 2026 at 97 shares worth $5.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

MCF Advisors first reported a position in PCVX in Q3 2024 and has held it in 8 quarters since. The position peaked at $11.4K in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • MCF Advisors held 97 shares of Vaxcyte worth $5.64K as of Q2 2026.
  • MCF Advisors left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1136 holding.
  • MCF Advisors first reported a position in Vaxcyte in Q3 2024 and has held it in 8 quarters since.
  • MCF Advisors's Vaxcyte position peaked at $11.4K in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.